ARCHIVES

Phase III Ramucirumab Trial Fails Primary Endpoint of PFS

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

Frederick RFP Held Up; NCI Probably Will Reject Any Further Delay

October 15, 1976

UNM Cancer Center Appoints Four Leaders

May 24, 2013

City of Hope Selects Michael Friedman As President, CEO

May 16, 2003

ONS Backs Independent Nursing Research, Splits From ASCO On Meetings

September 3, 1982

Cancer Panel To Examine Health Of Phase I Trials

May 17, 1996

Schmidt Says He Erred In Remarks About Pauling’s Grant Applications

March 23, 1979